COMMUNIQUÉS West-GlobeNewswire

Collegium Reports Third Quarter Financial Results
08/11/2018
Net Product Revenues were $70.2 million for the third quarter of 2018, a 487% increase versus third quarter of 2017 Thirteen exclusive ER oxycodone formulary wins announced for Xtampza ER effective January 1, 2019 Cash [...]
BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
08/11/2018
BELBUCA ® continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarter BELBUCA total prescriptions experienced its largest quarter over quarter increase since launch [...]
ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights
08/11/2018
-- Large, controlled clinical trial of avacopan in Hidradenitis Suppurativa (HS) on track to launch in late 2018 – -- $186 million in cash and investments at September 30, 2018 -- -- Received Orphan Drug Designation for [...]
Misonix Fiscal 2019 First Quarter Revenue Rises 29% to Record $9.4 Million
08/11/2018
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Alphatec Reports Third Quarter 2018 Financial and Corporate Highlights
08/11/2018
CARLSBAD, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC,” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
Inovio Pharmaceuticals Reports 2018 Third Quarter Financial Results
08/11/2018
PLYMOUTH MEETING, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted [...]
Dova Pharmaceuticals Reports Third Quarter 2018 Operating and Financial Results
08/11/2018
Third quarter net product sales of $2.9 million from DOPTELET ® (avatrombopag); 335 cumulative unique prescribers from launch through September 30, 2018 sNDA accepted for review by FDA for DOPTELET for the treatment of [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/11/2018
MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
KemPharm, Inc. Reports Third Quarter 2018 Results
08/11/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development Highlights: Announced positive topline results from KP415.E01 efficacy and safety trial in children with [...]
Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019
08/11/2018
• Total Revenue of $4.9 Million, up 13 % over June 2018 Quarter • Total Revenue up 14% over September 2017 Quarter Conference Call Begins at 4:30 pm EST Today PETALUMA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sonoma [...]
Viveve Reports Third Quarter 2018 Financial Results
08/11/2018
Continued commercial growth for Viveve ® System including record quarter of treatment tip sales Significant advancement of clinical programs targeting new indications in sexual function and stress urinary incontinence ( [...]
Yield10 Bioscience Announces Third Quarter 2018 Financial Results
08/11/2018
WOBURN, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
Helius Medical Technologies, Inc. Reports Third Quarter 2018 Financial Results
08/11/2018
NEWTOWN, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial [...]
FibroGen Reports Third Quarter 2018 Financial Results
08/11/2018
—Roxadustat New Drug Applications under Review in China and Japan— —Phase 3 Clinical Trials in IPF and Pancreatic Cancer to Initiate in First Quarter 2019— —Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. [...]
Bio-Path Holdings to Announce Third Quarter 2018 Financial Results on November 15, 2018
08/11/2018
HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted [...]
Nova Leap Health Corp. to Participate in the Inaugural RAI$E Quebec Small-Cap Investing Conference
08/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NOVA [...]
New Data Demonstrating the Clinical Utility of Daxor’s BVA-100 in Hypertension Management to be Presented at the American Heart Association’s Scientific Sessions 2018
08/11/2018
Daxor to Exhibit at American Heart Association 2018 NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology [...]
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services
08/11/2018
MIAMI, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc. (BRL) , an OPKO Health (NASDAQ: OPK) company and the third largest clinical laboratory in the United States, will remain an in-network provider [...]
EssilorLuxottica: Conditions for obtaining or consulting the documents prepared for the Ordinary and Extraordinary General Meeting of November 29, 2018
08/11/2018
Conditions for obtaining or consulting the documents prepared for the Ordinary and Extraordinary General Meeting of November 29, 2018 PDF version of the news release Charenton-le-Pont, France (November 8, 2018 - 6:00 pm [...]

Pages